Sutro Biopharma STRO Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's capital investments accrued but not yet paid?
- Sutro Biopharma (STRO) reported capital investments accrued but not yet paid of $0 in Q1 2026.
- How has Sutro Biopharma's capital investments accrued but not yet paid changed year-over-year?
- Sutro Biopharma's capital investments accrued but not yet paid decreased by 100.0% year-over-year, from $27K to $0.